Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
INDSWFTLAB Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low and declining operating margin
Company's earnings are of low quality
Low dividend yield
Neutral
High ROE but declining trend
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
INDSWFTLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
INDSWFTLAB Bulk, Block & Insider Trades
INDSWFTLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Compan... Read More
Key personnel
Shri. Navrattan R. MunjalD
Executive Chairman of the Board, Managing Director
Mr. Gagan Aggarwal
Chief Financial Officer
Shri. Vikas Narendra
President - US Operations
Rakesh Bahuguna
Senior Vice President - QC
Anurag Chaturvedi
Senior Vice President - Marketing
Varun Chhabra
Senior Vice President - Marketing
Ashok Prasad
Senior Vice President - R&D
Sandeep Singh
Senior Vice President - Procurement
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Ind-Swift Laboratories Ltd.?
The current share price of Ind-Swift Laboratories Ltd. is ₹ 90.53 as of 09 Jan 2026.
What is the PE ratio of Ind-Swift Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Ind-Swift Laboratories Ltd. is 2.50 as of the latest financial data.
What is the ROE and ROCE of Ind-Swift Laboratories Ltd.?
Ind-Swift Laboratories Ltd. has a Return on Equity (ROE) of 22.94% and a Return on Capital Employed (ROCE) of -2.58% as per the latest financial reports.
What is the market cap of Ind-Swift Laboratories Ltd.?
The market capitalization of Ind-Swift Laboratories Ltd. stands at ₹ 665.28 Cr.
What is the dividend yield of Ind-Swift Laboratories Ltd.?
The dividend yield of Ind-Swift Laboratories Ltd. is 0.00% based on the current market price.
What is the RSI of Ind-Swift Laboratories Ltd.?
The Relative Strength Index (RSI) of Ind-Swift Laboratories Ltd. is 44.53.
What is the FII and DII holding in Ind-Swift Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 14.80% and Domestic Institutional Investors (DII) hold 0.00% of Ind-Swift Laboratories Ltd. shares.
What sector does Ind-Swift Laboratories Ltd. belong to?
Ind-Swift Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Ind-Swift Laboratories Ltd. stock?
The beta of Ind-Swift Laboratories Ltd. stock is 0.93, indicating its volatility relative to the broader market.
